|
NADK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.000770E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.370620E-01 |
| Normal-vs-Stage2 |
1.123830E-01 |
| Normal-vs-Stage3 |
1.171560E-01 |
| Normal-vs-Stage4 |
2.904000E-01 |
| Stage1-vs-Stage2 |
4.804000E-01 |
| Stage1-vs-Stage3 |
7.163800E-01 |
| Stage1-vs-Stage4 |
7.751200E-01 |
| Stage2-vs-Stage3 |
6.982600E-01 |
| Stage2-vs-Stage4 |
4.155200E-01 |
| Stage3-vs-Stage4 |
5.883600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.855800E-02 |
| Normal-vs-AfricanAmerican |
7.469400E-01 |
| Normal-vs-Asian |
1.822570E-01 |
| Caucasian-vs-AfricanAmerican |
2.235700E-02 |
| Caucasian-vs-Asian |
2.602300E-02 |
| AfricanAmerican-vs-Asian |
2.762000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.648100E-02 |
| Normal-vs-Female |
5.718400E-01 |
| Male-vs-Female |
2.315800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.292000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.965770E-01 |
| Normal-vs-Age(61-80Yrs) |
1.184360E-01 |
| Normal-vs-Age(81-100Yrs) |
9.418100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.776800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.372200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.877800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.401000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.868200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.061800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.554600E-01 |
| Normal-vs-Grade 2 |
1.346960E-01 |
| Normal-vs-Grade 3 |
3.701900E-02 |
| Normal-vs-Grade 4 |
9.122400E-01 |
| Grade 1-vs-Grade 2 |
4.166000E-01 |
| Grade 1-vs-Grade 3 |
2.643400E-01 |
| Grade 1-vs-Grade 4 |
9.016400E-01 |
| Grade 2-vs-Grade 3 |
3.537200E-01 |
| Grade 2-vs-Grade 4 |
1.583840E-01 |
| Grade 3-vs-Grade 4 |
4.276000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.058000E-03 |
| Normal-vs-ccB subtype |
4.614200E-01 |
| ccA subtype-vs-ccB subtype |
1.662080E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.530100E-02 |
| Normal-vs-N1 |
2.726000E-01 |
| N0-vs-N1 |
3.006000E-02 |
|
|
